We are live on ! Find out more
CCA

Cravens & Co Advisors Portfolio holdings

AUM $154M
1-Year Est. Return 17.67%
This Fund
S&P 500
This Quarter Est. Return
+9.61%
1 Year Est. Return
+17.67%
3 Year Est. Return
+52.1%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$134M
AUM Growth
+$5.29M
Cap. Flow
-$4.95M
Cap. Flow %
-3.7%
Top 10 Hldgs %
67.11%
Holding
59
New
2
Increased
29
Reduced
20
Closed
4

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$1.19M
2
SBUX icon
Starbucks
SBUX
+$782K
3
DFSV
Dimensional US Small Cap Value ETF
DFSV
+$427K
4
ILMN icon
Illumina
ILMN
+$298K
5
DFAC icon
Dimensional US Core Equity 2 ETF
DFAC
+$279K

Top Sells

Rank Stock Value
1
SMBK icon
SmartFinancial
SMBK
+$4.94M
2
ABBV icon
AbbVie
ABBV
+$1.02M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$816K
4
RIO icon
Rio Tinto
RIO
+$723K
5
CVE icon
Cenovus Energy
CVE
+$276K

Sector Composition

Rank Sector Weight
1 Financials 11.03%
2 Technology 6.7%
3 Communication Services 4.56%
4 Consumer Discretionary 3.99%
5 Healthcare 3.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GE icon
26
GE Aerospace
GE
$367B
$1.24M 0.92%
4,815
-72
-1% -$15.8K
LLY icon
27
Eli Lilly
LLY
$1.07T
$1.2M 0.89%
+1,534
New +$1.19M
ABT icon
28
Abbott
ABT
$180B
$1.17M 0.88%
8,625
-21
-0.2% -$2.77K
USB icon
29
US Bancorp
USB
$99.6B
$1.14M 0.85%
25,212
– –
SE icon
30
Sea Limited
SE
$61.2B
$1.09M 0.81%
6,811
-134
-2% -$19.4K
VRTX icon
31
Vertex Pharmaceuticals
VRTX
$121B
$998K 0.74%
2,241
+63
+3% +$29K
EOG icon
32
EOG Resources
EOG
$78B
$996K 0.74%
8,326
+120
+1% +$13.7K
LOW icon
33
Lowe's Companies
LOW
$116B
$933K 0.7%
4,203
+39
+0.9% +$8.7K
SHOP icon
34
Shopify
SHOP
$148B
$862K 0.64%
7,472
-194
-3% -$19.4K
NET icon
35
Cloudflare
NET
$93B
$859K 0.64%
4,389
-107
-2% -$15.5K
AFRM icon
36
Affirm
AFRM
$23.5B
$784K 0.59%
11,343
-253
-2% -$13.1K
TOST icon
37
Toast
TOST
$16.8B
$695K 0.52%
15,702
-353
-2% -$13.9K
NVO
38
Novo Nordisk
NVO
$216B
$636K 0.47%
9,210
+177
+2% +$12K
IVV icon
39
iShares Core S&P 500 ETF
IVV
$876B
$559K 0.42%
900
– –
AAPL icon
40
Apple
AAPL
$4.89T
$545K 0.41%
2,657
+3
+0.1% +$606
CGUS icon
41
Capital Group Core Equity ETF
CGUS
$11.1B
$464K 0.35%
12,551
-1,681
-12% -$57.3K
MO icon
42
Altria Group
MO
$122B
$444K 0.33%
7,574
+77
+1% +$4.52K
ILMN icon
43
Illumina
ILMN
$29.4B
$351K 0.26%
+3,678
New +$298K
BAC icon
44
Bank of America
BAC
$435B
$317K 0.24%
6,700
– –
DUK icon
45
Duke Energy
DUK
$102B
$317K 0.24%
2,683
+56
+2% +$6.61K
TRP icon
46
TC Energy
TRP
$73.5B
$316K 0.24%
6,469
+129
+2% +$6.33K
GSK icon
47
GSK
GSK
$103B
$298K 0.22%
7,759
+170
+2% +$6.5K
CNQ icon
48
Canadian Natural Resources
CNQ
$96.9B
$289K 0.22%
9,190
+155
+2% +$4.7K
VOE icon
49
Vanguard Mid-Cap Value ETF
VOE
$23.7B
$257K 0.19%
1,560
-212
-12% -$33.6K
BMY icon
50
Bristol-Myers Squibb
BMY
$127B
$250K 0.19%
5,392
+88
+2% +$4.32K
1
2
3

Similar funds

CPCP
Cedar Point Capital Partners Cedar Rapids, Iowa $154M AUM 16.57% 1-Year Est. Return
SOWAS
Silver Oak Wealth Advisors Services Los Angeles, California $154M AUM 13.96% 1-Year Est. Return
AFC
Alpine Fox Capital Las Vegas, Nevada $154M AUM
SHU
SBI Holdings USA Santa Clara, California $154M AUM
FW
Fidato Wealth Middleburg Heights, Ohio $154M AUM 11.98% 1-Year Est. Return
FGI
Foresight Global Investors Purchase, New York $154M AUM 26.15% 1-Year Est. Return
HPM
H. Partners Management New York $154M AUM 19.94% 1-Year Est. Return
MDP
Millbank Dartmoor Portsmouth Asheville, North Carolina $154M AUM

Cravens & Co Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Cravens & Co Advisors held 59 positions worth $134M, up 4.1% from $129M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Cravens & Co Advisors withdrew a net $4.95M in Q2 2025, closing 4 positions and reducing 20 holdings. Its most notable exit was AbbVie, an estimated $1.02M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 14% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Cravens & Co Advisors opened a new position in Eli Lilly worth $1.2M.

  • Cravens & Co Advisors's largest Q2 2025 buy was Eli Lilly: 1,534 shares worth $1.2M.
  • Cravens & Co Advisors added most to Starbucks in Q2 2025, an estimated $782K increase.
  • Cravens & Co Advisors's biggest Q2 2025 reduction was SmartFinancial, cutting an estimated $4.94M.
  • Cravens & Co Advisors fully exited AbbVie in Q2 2025, selling an estimated $1.02M.
  • Cravens & Co Advisors's ten largest holdings make up 67% of its $134M portfolio in Q2 2025.
  • Cravens & Co Advisors opened 2 new positions and closed 4 in Q2 2025.
  • Cravens & Co Advisors's portfolio value rose 4.1% quarter-over-quarter to $134M.

Based on Cravens & Co Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.